These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26548427)

  • 1. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
    Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
    Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organogel Nanoparticles as a New Way to Improve Oral Bioavailability of Poorly Soluble Compounds.
    Martin B; Garrait G; Beyssac E; Goudouneche D; Perez E; Franceschi S
    Pharm Res; 2020 May; 37(6):92. PubMed ID: 32394200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of organogels as oral controlled release formulations of hydrophilic drugs.
    Iwanaga K; Kawai M; Miyazaki M; Kakemi M
    Int J Pharm; 2012 Oct; 436(1-2):869-72. PubMed ID: 22766444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents.
    Esposito CL; Tardif V; Sarrazin M; Kirilov P; Roullin VG
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():110999. PubMed ID: 32993979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
    Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
    Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olive oil/policosanol organogels for nutraceutical and drug delivery purposes.
    Lupi FR; Gabriele D; Baldino N; Mijovic P; Parisi OI; Puoci F
    Food Funct; 2013 Oct; 4(10):1512-20. PubMed ID: 24056806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
    García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF
    Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combined technique based on prilling and microwave assisted treatments for the production of ketoprofen controlled release dosage forms.
    Auriemma G; Del Gaudio P; Barba AA; d'Amore M; Aquino RP
    Int J Pharm; 2011 Aug; 415(1-2):196-205. PubMed ID: 21679754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of sorbitan monostearate and sesame oil-based organogels for topical delivery of antimicrobials.
    Singh VK; Pramanik K; Ray SS; Pal K
    AAPS PharmSciTech; 2015 Apr; 16(2):293-305. PubMed ID: 25277240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation.
    Li Z; Cao J; Li H; Liu H; Han F; Liu Z; Tong C; Li S
    Drug Deliv; 2016 Oct; 23(8):3168-3178. PubMed ID: 26912188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gelatin-based emulsion gels for diffusion-controlled release applications.
    Thakur G; Naqvi MA; Rousseau D; Pal K; Mitra A; Basak A
    J Biomater Sci Polym Ed; 2012; 23(5):645-61. PubMed ID: 21418746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium alginate in oil-poloxamer organogels for intravaginal drug delivery: Influence on structural parameters, drug release mechanisms, cytotoxicity and in vitro antifungal activity.
    Querobino SM; de Faria NC; Vigato AA; da Silva BGM; Machado IP; Costa MS; Costa FN; de Araujo DR; Alberto-Silva C
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1350-1361. PubMed ID: 30889669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of superdisintegrants on efavirenz release from tablet formulations.
    Rajesh YV; Balasubramaniam J; Bindu K; Sridevi R; Swetha M; Rao VU
    Acta Pharm; 2010 Jun; 60(2):185-95. PubMed ID: 21134855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of aqueous ternary nanomatrix films: A novel 'green' strategy for the delivery of poorly soluble drugs.
    Kola-Mustapha AT; Armitage D; Abioye AO
    Int J Pharm; 2016 Dec; 515(1-2):616-631. PubMed ID: 27825861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organogels based on amino acid derivatives and their optimization for drug release using response surface methodology.
    Hu B; Yan H; Sun Y; Chen X; Sun Y; Li S; Jing Y; Li H
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):266-275. PubMed ID: 31851842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
    Galal S; El Massik MA; Abdallah OY; Daabis NA
    Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.